Symphony Evolution, Inc.
Rockville, MD, US· latest recorded location
SYMPHONY EVOLUTION, INC. is named on 11 US grants and 15 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 11
- Published applications
- 15
- Inventors
- 34
- Granted in 2026 so far
- 0
- Most recent grant
- 23 Apr 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 2 | 1 |
| 2010 | 0 | 1 |
| 2011 | 1 | 2 |
| 2012 | 0 | 2 |
| 2013 | 1 | 2 |
| 2014 | 1 | 2 |
| 2015 | 1 | 0 |
| 2016 | 2 | 2 |
| 2017 | 1 | 0 |
| 2018 | 1 | 1 |
| 2019 | 1 | 0 |
By publication year.
Technology areas
Share of 26 documents
Recent patents
- Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof23 Apr 2019US 10,266,518 B2
- Use of a receptor-type kinase modulator for treating polycystic kidney disease1 May 2018US 9,956,221 B2
- Substituted quinazolines as receptor-type kinase inhibitors24 Oct 2017US 9,796,704 B2
- Use of a receptor-type kinase modulator for treating polycystic kidney disease14 Jun 2016US 9,364,479 B2
- Processes for the preparation of substituted quinazolines7 Jun 2016US 9,359,332 B2
- Receptor-Type Kinase Modulators and Methods of Use3 May 2018US 2018/0118724 A1
- Use of a Receptor-Type Kinase Modulator for Treating Polycystic Kidney Disease22 Dec 2016US 2016/0367555 A1
- Receptor-Type Kinase Modulators and Methods of Use12 May 2016US 2016/0129032 A1
- Human Adam-10 Inhibitors24 Jul 2014US 2014/0206865 A1
- Receptor-Type Kinase Modulators and Methods of Use5 Jun 2014US 2014/0155418 A1
Most cited
By later US patents